In our NSCLC cohort, we have now confirmed other investigators’ findings that CTCs coexpress PD-L1 and EMT markers vimentin and N-Cadherin as a possible mechanism for immune escape [23]. The gene discussed is CDH2; the disease is non-small cell lung carcinoma.